Global and United States Biosimulation In-Depth Research Report 2017-2022

Published: Oct, 2017 | Pages: 100 | Publisher: US Market Insight (UMI)
Industry: ICT | Report Format: Electronic (PDF)

The report is based on the market historical data from 2012 to 2016 and forecast the market trend from 2017 to 2022.

This report focuses on the U.S. market and presents volume and value of market share by players, by regions, by product type, by consumers and also changes in prices. As an in-depth report, it covers all details inside analysis and opinions in Biosimulation industry.

Major Companies

• Certara USA, Inc. (U.S.)
• Simulation Plus Inc. (U.S.)
• Dassault Systemes SA (France)
• Schrodinger Inc. (U.S.)
• Advanced Chemistry Development, Inc. (Canada)
• Chemical Computing Group, Inc. (Canada)
• Physiomics PLC (U.K.)
• Entelos Holding Corporation (U.S.)
• Rhenovia Pharma Ltd. (France)
• Genedata AG (Switzerland)

Key Regions

• North America
• United States
• California
• Texas
• New York
• Others
• Canada
• Latin America
• Mexico
• Brazil
• Argentina
• Others
• Europe
• Germany
• United Kingdom
• France
• Italy
• Spain
• Russia
• Netherland
• Others
• Asia & Pacific
• China
• Japan
• India
• Korea
• Australia
• Southeast Asia
• Indonesia
• Thailand
• Philippines
• Vietnam
• Singapore
• Malaysia
• Others
• Africa & Middle East
• South Africa
• Egypt
• Turkey
• Saudi Arabia
• Iran
• Others

Main types of products

Biosimulation Market, by Segmentation

• Software
• Services

Biosimulation Market, by Phase

• Drug Development
• Drug Discovery
• Others

Biosimulation Market, by Key Consumers

• Academic and Government Research Institutes
• Pharmaceutical and Biotechnology Companies
• Contract Research Organization
• Regulatory Authorities
• Others

 Table of Contents

Global and United States Biosimulation In-Depth Research Report 2017-2022

Chapter One Global Biosimulation Market Overview
    1.1 Global Biosimulation Market Sales Volume Revenue and Price 2012-2017
    1.2 Biosimulation, by Segmentation 2012-2017
        1.2.1 Global Biosimulation Sales Market Share by Segmentation 2012-2017
        1.2.2 Global Biosimulation Revenue Market Share by Segmentation 2012-2017
        1.2.3 Global Biosimulation Price by Segmentation 2012-2017
        1.2.4 Software
        1.2.5 Services
    1.3 Biosimulation, by Phase 2012-2017
        1.3.1 Global Biosimulation Sales Market Share by Phase 2012-2017
        1.3.2 Global Biosimulation Revenue Market Share by Phase 2012-2017
        1.3.3 Global Biosimulation Price by Phase 2012-2017
        1.3.4 Drug Development
        1.3.5 Drug Discovery
        1.3.6 Others

Chapter Two United States Biosimulation Market Overview
    2.1 United States Biosimulation Market Sales Volume Revenue and Price 2012-2017
    2.2 Biosimulation, by Segmentation 2012-2017
        2.2.1 United States Biosimulation Sales Market Share by Segmentation 2012-2017
        2.2.2 United States Biosimulation Revenue Market Share by Segmentation 2012-2017
        2.2.3 United States Biosimulation Price by Segmentation 2012-2017
        2.2.4 Software
        2.2.5 Services
    2.3 Biosimulation, by Phase 2012-2017
        2.3.1 United States Biosimulation Sales Market Share by Phase 2012-2017
        2.3.2 United States Biosimulation Revenue Market Share by Phase 2012-2017
        2.3.3 United States Biosimulation Price by Phase 2012-2017
        2.3.4 Drug Development
        2.3.5 Drug Discovery
        2.3.6 Others

Chapter Three Biosimulation by Regions 2012-2017
    3.1 Global Biosimulation Sales Market Share by Regions 2012-2017
    3.2 Global Biosimulation Revenue Market Share by Regions 2012-2017
    3.3 Global Biosimulation Price by Regions 2012-2017
    3.4 North America
        3.4.1 United States
            3.4.1.1 California
            3.4.1.2 Texas
            3.4.1.3 New York
            3.4.1.4 Others in United States
        3.4.2 Canada
    3.5 Latin America
        3.5.1 Mexico
        3.5.2 Brazil
        3.5.3 Argentina
        3.5.4 Others in Latin America
    3.6 Europe
        3.6.1 Germany
        3.6.2 United Kingdom
        3.6.3 France
        3.6.4 Italy
        3.6.5 Spain
        3.6.6 Russia
        3.6.7 Netherland
        3.6.8 Others in Europe
    3.7 Asia & Pacific
        3.7.1 China
        3.7.2 Japan
        3.7.3 India
        3.7.4 Korea
        3.7.5 Australia
        3.7.6 Southeast Asia
            3.7.6.1 Indonesia
            3.7.6.2 Thailand
            3.7.6.3 Philippines
            3.7.6.4 Vietnam
            3.7.6.5 Singapore
            3.7.6.6 Malaysia
            3.7.6.7 Others in Southeast Asia
    3.8 Africa & Middle East
        3.8.1 South Africa
        3.8.2 Egypt
        3.8.3 Turkey
        3.8.4 Saudi Arabia
        3.8.5 Iran
        3.8.6 Others in Africa & Middle East

Chapter Four Global Biosimulation by Companies 2012-2017
    4.1 Global Biosimulation Sales Volume Market Share by Companies 2012-2017
    4.2 Global Biosimulation Revenue Share by Companies 2012-2017
    4.3 Global Top Companies Biosimulation Key Product Model and Market Performance
    4.4 Global Top Companies Biosimulation Key Target Consumers and Market Performance

Chapter Five United States Biosimulation by Companies 2012-2017
    5.1 United States Biosimulation Sales Volume Market Share by Companies 2012-2017
    5.2 United States Biosimulation Revenue Share by Companies 2012-2017
    5.3 United States Top Companies Biosimulation Key Product Model and Market Performance
    5.4 United States Top Companies Biosimulation Key Target Consumers and Market Performance

Chapter Six Global Biosimulation by Consumer 2012-2017
    6.1 Global Biosimulation Sales Market Share by Consumer 2012-2017
    6.2 Academic and Government Research Institutes
    6.3 Pharmaceutical and Biotechnology Companies
    6.4 Contract Research Organization
    6.5 Regulatory Authorities
    6.6 Others
    6.7 Consuming Habit and Preference

Chapter Seven Global Biosimulation by Consumer 2012-2017
    7.1 Global Biosimulation Sales Market Share by Consumer 2012-2017
    7.2 Academic and Government Research Institutes
    7.3 Pharmaceutical and Biotechnology Companies
    7.4 Contract Research Organization
    7.5 Regulatory Authorities
    7.6 Others
    7.7 Consuming Habit and Preference

Chapter Eight Top Companies Profile
    8.1 Certara USA, Inc. (U.S.)
        8.1.1 Certara USA, Inc. (U.S.) Company Details and Competitors
        8.1.2 Certara USA, Inc. (U.S.) Key Biosimulation Models and Performance
        8.1.3 Certara USA, Inc. (U.S.) Biosimulation Business SWOT Analysis and Forecast
        8.1.4 Certara USA, Inc. (U.S.) Biosimulation Sales Volume Revenue Price Cost and Gross Margin
    8.2 Simulation Plus Inc. (U.S.)
        8.2.1 Simulation Plus Inc. (U.S.) Company Details and Competitors
        8.2.2 Simulation Plus Inc. (U.S.) Key Biosimulation Models and Performance
        8.2.3 Simulation Plus Inc. (U.S.) Biosimulation Business SWOT Analysis and Forecast
        8.2.4 Simulation Plus Inc. (U.S.) Biosimulation Sales Volume Revenue Price Cost and Gross Margin
    8.3 Dassault Systemes SA (France)
        8.3.1 Dassault Systemes SA (France) Company Details and Competitors
        8.3.2 Dassault Systemes SA (France) Key Biosimulation Models and Performance
        8.3.3 Dassault Systemes SA (France) Biosimulation Business SWOT Analysis and Forecast
        8.3.4 Dassault Systemes SA (France) Biosimulation Sales Volume Revenue Price Cost and Gross Margin
    8.4 Schrodinger Inc. (U.S.)
        8.4.1 Schrodinger Inc. (U.S.) Company Details and Competitors
        8.4.2 Schrodinger Inc. (U.S.) Key Biosimulation Models and Performance
        8.4.3 Schrodinger Inc. (U.S.) Biosimulation Business SWOT Analysis and Forecast
        8.4.4 Schrodinger Inc. (U.S.) Biosimulation Sales Volume Revenue Price Cost and Gross Margin
    8.5 Advanced Chemistry Development, Inc. (Canada)
        8.5.1 Advanced Chemistry Development, Inc. (Canada) Company Details and Competitors
        8.5.2 Advanced Chemistry Development, Inc. (Canada) Key Biosimulation Models and Performance
        8.5.3 Advanced Chemistry Development, Inc. (Canada) Biosimulation Business SWOT Analysis and Forecast
        8.5.4 Advanced Chemistry Development, Inc. (Canada) Biosimulation Sales Volume Revenue Price Cost and Gross Margin
    8.6 Chemical Computing Group, Inc. (Canada)
        8.6.1 Chemical Computing Group, Inc. (Canada) Company Details and Competitors
        8.6.2 Chemical Computing Group, Inc. (Canada) Key Biosimulation Models and Performance
        8.6.3 Chemical Computing Group, Inc. (Canada) Biosimulation Business SWOT Analysis and Forecast
        8.6.4 Chemical Computing Group, Inc. (Canada) Biosimulation Sales Volume Revenue Price Cost and Gross Margin
    8.7 Physiomics PLC (U.K.)
        8.7.1 Physiomics PLC (U.K.) Company Details and Competitors
        8.7.2 Physiomics PLC (U.K.) Key Biosimulation Models and Performance
        8.7.3 Physiomics PLC (U.K.) Biosimulation Business SWOT Analysis and Forecast
        8.7.4 Physiomics PLC (U.K.) Biosimulation Sales Volume Revenue Price Cost and Gross Margin
    8.8 Entelos Holding Corporation (U.S.)
        8.8.1 Entelos Holding Corporation (U.S.) Company Details and Competitors
        8.8.2 Entelos Holding Corporation (U.S.) Key Biosimulation Models and Performance
        8.8.3 Entelos Holding Corporation (U.S.) Biosimulation Business SWOT Analysis and Forecast
        8.8.4 Entelos Holding Corporation (U.S.) Biosimulation Sales Volume Revenue Price Cost and Gross Margin
    8.9 Rhenovia Pharma Ltd. (France)
        8.9.1 Rhenovia Pharma Ltd. (France) Company Details and Competitors
        8.9.2 Rhenovia Pharma Ltd. (France) Key Biosimulation Models and Performance
        8.9.3 Rhenovia Pharma Ltd. (France) Biosimulation Business SWOT Analysis and Forecast
        8.9.4 Rhenovia Pharma Ltd. (France) Biosimulation Sales Volume Revenue Price Cost and Gross Margin
    8.10 Genedata AG (Switzerland)
        8.10.1 Genedata AG (Switzerland) Company Details and Competitors
        8.10.2 Genedata AG (Switzerland) Key Biosimulation Models and Performance
        8.10.3 Genedata AG (Switzerland) Biosimulation Business SWOT Analysis and Forecast
        8.10.4 Genedata AG (Switzerland) Biosimulation Sales Volume Revenue Price Cost and Gross Margin

Chapter Nine Industry Chain and Supply Chain
    9.1 Biosimulation Industry Chain Structure
        9.1.1 R&D
        9.1.2 Raw Materials (Components)
        9.1.3 Manufacturing Plants
        9.1.4 Regional Trading (Import Export and Local Sales)
        9.1.5 Online Sales Channel
        9.1.6 Offline Channel
        9.1.7 End Users
    9.2 Biosimulation Manufacturing
        9.2.1 Key Components
        9.2.2 Assembly Manufacturing
    9.3 Consumer Preference
    9.4 Behavioral Habits
    9.5 Marketing Environment

Chapter Ten Global Biosimulation Market Size (Sales and Revenue) Forecast (2017-2022)
    10.1 Global Biosimulation Sales (K Units), Revenue (Million USD) Forecast (2017-2022)
    10.2 Global Biosimulation Sales (K Units) Forecast by Regions (2017-2022)
    10.3 Global Biosimulation Sales (K Units) Forecast by Application (2017-2022)
    10.4 Global Biosimulation Sales (K Units) Forecast by Segmentation (2017-2022)
    10.5 Global Biosimulation Sales (K Units) Forecast by Phase (2017-2022)

Chapter Eleven United States Biosimulation Market Size (Sales and Revenue) Forecast (2017-2022)
    11.1 United States Biosimulation Sales (K Units), Revenue (Million USD) Forecast (2017-2022)
    11.2 United States Biosimulation Sales (K Units) Forecast by Regions (2017-2022)
    11.3 United States Biosimulation Sales (K Units) Forecast by Application (2017-2022)
    11.4 United States Biosimulation Sales (K Units) Forecast by Segmentation (2017-2022)
    11.5 United States Biosimulation Sales (K Units) Forecast by Phase (2017-2022)

Chapter Twelve Development Trend and Research Conclusion
    12.1 Development Trend
    12.2 Research Conclusion

Chapter Thirteen Methodology and Data Source
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer

List of Tables and Figures

    Table Global Biosimulation Sales Volume (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
    Figure Global Biosimulation Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Global Biosimulation Sales Volume (K Units) and Growth Rate (2012-2017)
    Table Global Biosimulation Sales (K Units) by Segmentation (2012-2017)
    Table Global Biosimulation Sales Market Share by Segmentation (2012-2017)
    Figure Global Biosimulation Sales Market Share by Segmentation in 2016
    Table Global Biosimulation Revenue (Million USD) by Segmentation (2012-2017)
    Table Global Biosimulation Revenue Market Share by Segmentation (2012-2017)
    Figure Global Biosimulation Revenue Market Share by Segmentation in 2016
    Table Global Biosimulation Price (USD/Unit) by Segmentation (2012-2017)
    Table Top Companies of Software Biosimulation Products List
    Figure Global Software Biosimulation Sales (K Units) and Growth Rate (2012-2017)
    Table Top Companies of Services Biosimulation Products List
    Figure Global Services Biosimulation Sales (K Units) and Growth Rate (2012-2017)
    Table Global Biosimulation Sales (K Units) by Phase (2012-2017)
    Table Global Biosimulation Sales Market Share by Phase (2012-2017)
    Figure Global Biosimulation Sales Market Share by Phase in 2016
    Table Global Biosimulation Revenue (Million USD) by Phase (2012-2017)
    Table Global Biosimulation Revenue Market Share by Phase (2012-2017)
    Figure Global Biosimulation Revenue Market Share by Phase in 2016
    Table Global Biosimulation Price (USD/Unit) by Phase (2012-2017)
    Table Top Companies of Drug Development Biosimulation Products List
    Figure Global Drug Development Biosimulation Sales (K Units) and Growth Rate (2012-2017)
    Table Top Companies of Drug Discovery Biosimulation Products List
    Figure Global Drug Discovery Biosimulation Sales (K Units) and Growth Rate (2012-2017)
    Table Top Companies of Others Biosimulation Products List
    Figure Global Others Biosimulation Sales (K Units) and Growth Rate (2012-2017)
    Figure United States Biosimulation Revenue (Million USD) and Growth Rate (2012-2017)
    Figure United States Biosimulation Sales Volume (K Units) and Growth Rate (2012-2017)
    Table United States Biosimulation Sales (K Units) by Segmentation (2012-2017)
    Table United States Biosimulation Sales Market Share by Segmentation (2012-2017)
    Figure United States Biosimulation Sales Market Share by Segmentation in 2016
    Table United States Biosimulation Revenue (Million USD) by Segmentation (2012-2017)
    Table United States Biosimulation Revenue Market Share by Segmentation (2012-2017)
    Figure United States Biosimulation Revenue Market Share by Segmentation in 2016
    Table United States Biosimulation Price (USD/Unit) by Segmentation (2012-2017)
    Table Top Companies of Software Biosimulation Products List
    Figure United States Software Biosimulation Sales (K Units) and Growth Rate (2012-2017)
    Table Top Companies of Services Biosimulation Products List
    Figure United States Services Biosimulation Sales (K Units) and Growth Rate (2012-2017)
    Table United States Biosimulation Sales (K Units) by Phase (2012-2017)
    Table United States Biosimulation Sales Market Share by Phase (2012-2017)
    Figure United States Biosimulation Sales Market Share by Phase in 2016
    Table United States Biosimulation Revenue (Million USD) by Phase (2012-2017)
    Table United States Biosimulation Revenue Market Share by Phase (2012-2017)
    Figure United States Biosimulation Revenue Market Share by Phase in 2016
    Table United States Biosimulation Price (USD/Unit) by Phase (2012-2017)
    Table Top Companies of Drug Development Biosimulation Products List
    Figure United States Drug Development Biosimulation Sales (K Units) and Growth Rate (2012-2017)
    Table Top Companies of Drug Discovery Biosimulation Products List
    Figure United States Drug Discovery Biosimulation Sales (K Units) and Growth Rate (2012-2017)
    Table Top Companies of Others Biosimulation Products List
    Figure United States Others Biosimulation Sales (K Units) and Growth Rate (2012-2017)
    Table Global Biosimulation Sales (K Units) by Regions (2012-2017)
    Table Global Biosimulation Sales Share by Regions (2012-2017)
    Figure Global Biosimulation Sales Market Share by Regions in 2016
    Figure Global Biosimulation Sales Market Share by Regions in 2017
    Table Global Biosimulation Revenue (Million USD) and Market Share by Regions (2012-2017)
    Table Global Biosimulation Revenue Market Share by Regions (2012-2017)
    Figure Global Biosimulation Revenue Market Share by Regions in 2016
    Figure Global Biosimulation Revenue Market Share by Regions in 2017
    Table Global Biosimulation Price (USD/Unit) by Regions (2012-2017)
    Table North America Biosimulation Sales (K Units) by Regions (2012-2017)
    Table North America Biosimulation Revenue (Million USD) by Regions (2012-2017)
    Figure North America Biosimulation Sales (K Units) and Growth Rate (2012-2017)
    Table United States Biosimulation Sales (K Units) by Regions (2012-2017)
    Table United States Biosimulation Revenue (Million USD) by Regions (2012-2017)
    Figure United States Biosimulation Sales (K Units) and Growth Rate (2012-2017)
    Table Latin America Biosimulation Sales (K Units) by Regions (2012-2017)
    Table Latin America Biosimulation Revenue (Million USD) by Regions (2012-2017)
    Figure Latin America Biosimulation Sales (K Units) and Growth Rate (2012-2017)
    Table Europe Biosimulation Sales (K Units) by Regions (2012-2017)
    Table Europe Biosimulation Revenue (Million USD) by Regions (2012-2017)
    Figure Europe Biosimulation Sales (K Units) and Growth Rate (2012-2017)
    Table Asia & Pacific Biosimulation Sales (K Units) by Regions (2012-2017)
    Table Asia & Pacific Biosimulation Revenue (Million USD) by Regions (2012-2017)
    Figure Asia & Pacific Biosimulation Sales (K Units) and Growth Rate (2012-2017)
    Table Africa & Middle East Biosimulation Sales (K Units) by Regions (2012-2017)
    Table Africa & Middle East Biosimulation Revenue (Million USD) by Regions (2012-2017)
    Figure Africa & Middle East Biosimulation Sales (K Units) and Growth Rate (2012-2017)
    Table Global Biosimulation Sales Volume (K Units) by Major Companies (2012-2017)
    Table Global Biosimulation Sales Volume Market Share by Major Companies (2012-2017)
    Figure Global Biosimulation Sales Volume Market Share by Major Companies 2016
    Figure Global Biosimulation Sales Volume Market Share by Major Companies 2017
    Table Global Biosimulation Revenue (Million USD) by Major Companies (2012-2017)
    Table Global Biosimulation Revenue Market Share by Major Companies (2012-2017)
    Figure Global Biosimulation Revenue Market Share by Major Companies 2016
    Figure Global Biosimulation Revenue Market Share by Major Companies 2017
    Table Global Top Companies Key Product Model and Market Performance
    Table Global Top Companies Key Target Consumers and Market Performance
    Table United States Biosimulation Sales Volume (K Units) by Top Companies (2012-2017)
    Table United States Biosimulation Sales Volume Market Share by Top Companies (2012-2017)
    Figure United States Biosimulation Sales Volume Market Share by Top Companies 2016
    Figure United States Biosimulation Sales Volume Market Share by Top Companies 2017
    Table United States Biosimulation Revenue (Million USD) by Top Companies (2012-2017)
    Table United States Biosimulation Revenue Market Share by Top Companies (2012-2017)
    Figure United States Biosimulation Revenue Market Share by Top Companies 2016
    Figure United States Biosimulation Revenue Market Share by Top Companies 2017
    Table United States Top Companies Key Product Model and Market Performance
    Table United States Top Companies Key Target Consumers and Market Performance
    Table Global Biosimulation Sales (K Units) by Consumer (2012-2017)
    Figure Global Biosimulation Sales Market Share by Consumer (2012-2017)
    Figure Global Biosimulation Sales Market Share by Consumer in 2016
    Figure Global Academic and Government Research Institutes Biosimulation Sales (K Units) and Growth Rate (2012-2017)
    Figure Global Pharmaceutical and Biotechnology Companies Biosimulation Sales (K Units) and Growth Rate (2012-2017)
    Figure Global Contract Research Organization Biosimulation Sales (K Units) and Growth Rate (2012-2017)
    Figure Global Regulatory Authorities Biosimulation Sales (K Units) and Growth Rate (2012-2017)
    Figure Global Others Biosimulation Sales (K Units) and Growth Rate (2012-2017)
    Table United States Biosimulation Sales (K Units) by Consumer (2012-2017)
    Figure United States Biosimulation Sales Market Share by Consumer (2012-2017)
    Figure United States Biosimulation Sales Market Share by Consumer in 2016
    Figure United States Academic and Government Research Institutes Biosimulation Sales (K Units) and Growth Rate (2012-2017)
    Figure United States Pharmaceutical and Biotechnology Companies Biosimulation Sales (K Units) and Growth Rate (2012-2017)
    Figure United States Contract Research Organization Biosimulation Sales (K Units) and Growth Rate (2012-2017)
    Figure United States Regulatory Authorities Biosimulation Sales (K Units) and Growth Rate (2012-2017)
    Figure United States Others Biosimulation Sales (K Units) and Growth Rate (2012-2017)
    Table Certara USA, Inc. (U.S.) Company Details and Competitors
    Table Certara USA, Inc. (U.S.) Key Biosimulation Models and Performance
    Table Certara USA, Inc. (U.S.) Biosimulation Business SWOT Analysis and Forecast
    Table Certara USA, Inc. (U.S.) Biosimulation Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
    Figure Certara USA, Inc. (U.S.) Biosimulation Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Certara USA, Inc. (U.S.) Biosimulation Sales Market Share (%) in Global (2012-2017)
    Figure Certara USA, Inc. (U.S.) Biosimulation Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Certara USA, Inc. (U.S.) Biosimulation Revenue Market Share (%) in Global (2012-2017)
    Table Simulation Plus Inc. (U.S.) Company Details and Competitors
    Table Simulation Plus Inc. (U.S.) Key Biosimulation Models and Performance
    Table Simulation Plus Inc. (U.S.) Biosimulation Business SWOT Analysis and Forecast
    Table Simulation Plus Inc. (U.S.) Biosimulation Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
    Figure Simulation Plus Inc. (U.S.) Biosimulation Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Simulation Plus Inc. (U.S.) Biosimulation Sales Market Share (%) in Global (2012-2017)
    Figure Simulation Plus Inc. (U.S.) Biosimulation Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Simulation Plus Inc. (U.S.) Biosimulation Revenue Market Share (%) in Global (2012-2017)
    Table Dassault Systemes SA (France) Company Details and Competitors
    Table Dassault Systemes SA (France) Key Biosimulation Models and Performance
    Table Dassault Systemes SA (France) Biosimulation Business SWOT Analysis and Forecast
    Table Dassault Systemes SA (France) Biosimulation Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
    Figure Dassault Systemes SA (France) Biosimulation Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Dassault Systemes SA (France) Biosimulation Sales Market Share (%) in Global (2012-2017)
    Figure Dassault Systemes SA (France) Biosimulation Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Dassault Systemes SA (France) Biosimulation Revenue Market Share (%) in Global (2012-2017)
    Table Schrodinger Inc. (U.S.) Company Details and Competitors
    Table Schrodinger Inc. (U.S.) Key Biosimulation Models and Performance
    Table Schrodinger Inc. (U.S.) Biosimulation Business SWOT Analysis and Forecast
    Table Schrodinger Inc. (U.S.) Biosimulation Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
    Figure Schrodinger Inc. (U.S.) Biosimulation Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Schrodinger Inc. (U.S.) Biosimulation Sales Market Share (%) in Global (2012-2017)
    Figure Schrodinger Inc. (U.S.) Biosimulation Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Schrodinger Inc. (U.S.) Biosimulation Revenue Market Share (%) in Global (2012-2017)
    Table Advanced Chemistry Development, Inc. (Canada) Company Details and Competitors
    Table Advanced Chemistry Development, Inc. (Canada) Key Biosimulation Models and Performance
    Table Advanced Chemistry Development, Inc. (Canada) Biosimulation Business SWOT Analysis and Forecast
    Table Advanced Chemistry Development, Inc. (Canada) Biosimulation Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
    Figure Advanced Chemistry Development, Inc. (Canada) Biosimulation Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Advanced Chemistry Development, Inc. (Canada) Biosimulation Sales Market Share (%) in Global (2012-2017)
    Figure Advanced Chemistry Development, Inc. (Canada) Biosimulation Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Advanced Chemistry Development, Inc. (Canada) Biosimulation Revenue Market Share (%) in Global (2012-2017)
    Table Chemical Computing Group, Inc. (Canada) Company Details and Competitors
    Table Chemical Computing Group, Inc. (Canada) Key Biosimulation Models and Performance
    Table Chemical Computing Group, Inc. (Canada) Biosimulation Business SWOT Analysis and Forecast
    Table Chemical Computing Group, Inc. (Canada) Biosimulation Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
    Figure Chemical Computing Group, Inc. (Canada) Biosimulation Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Chemical Computing Group, Inc. (Canada) Biosimulation Sales Market Share (%) in Global (2012-2017)
    Figure Chemical Computing Group, Inc. (Canada) Biosimulation Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Chemical Computing Group, Inc. (Canada) Biosimulation Revenue Market Share (%) in Global (2012-2017)
    Table Physiomics PLC (U.K.) Company Details and Competitors
    Table Physiomics PLC (U.K.) Key Biosimulation Models and Performance
    Table Physiomics PLC (U.K.) Biosimulation Business SWOT Analysis and Forecast
    Table Physiomics PLC (U.K.) Biosimulation Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
    Figure Physiomics PLC (U.K.) Biosimulation Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Physiomics PLC (U.K.) Biosimulation Sales Market Share (%) in Global (2012-2017)
    Figure Physiomics PLC (U.K.) Biosimulation Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Physiomics PLC (U.K.) Biosimulation Revenue Market Share (%) in Global (2012-2017)
    Table Entelos Holding Corporation (U.S.) Company Details and Competitors
    Table Entelos Holding Corporation (U.S.) Key Biosimulation Models and Performance
    Table Entelos Holding Corporation (U.S.) Biosimulation Business SWOT Analysis and Forecast
    Table Entelos Holding Corporation (U.S.) Biosimulation Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
    Figure Entelos Holding Corporation (U.S.) Biosimulation Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Entelos Holding Corporation (U.S.) Biosimulation Sales Market Share (%) in Global (2012-2017)
    Figure Entelos Holding Corporation (U.S.) Biosimulation Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Entelos Holding Corporation (U.S.) Biosimulation Revenue Market Share (%) in Global (2012-2017)
    Table Rhenovia Pharma Ltd. (France) Company Details and Competitors
    Table Rhenovia Pharma Ltd. (France) Key Biosimulation Models and Performance
    Table Rhenovia Pharma Ltd. (France) Biosimulation Business SWOT Analysis and Forecast
    Table Rhenovia Pharma Ltd. (France) Biosimulation Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
    Figure Rhenovia Pharma Ltd. (France) Biosimulation Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Rhenovia Pharma Ltd. (France) Biosimulation Sales Market Share (%) in Global (2012-2017)
    Figure Rhenovia Pharma Ltd. (France) Biosimulation Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Rhenovia Pharma Ltd. (France) Biosimulation Revenue Market Share (%) in Global (2012-2017)
    Table Genedata AG (Switzerland) Company Details and Competitors
    Table Genedata AG (Switzerland) Key Biosimulation Models and Performance
    Table Genedata AG (Switzerland) Biosimulation Business SWOT Analysis and Forecast
    Table Genedata AG (Switzerland) Biosimulation Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
    Figure Genedata AG (Switzerland) Biosimulation Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Genedata AG (Switzerland) Biosimulation Sales Market Share (%) in Global (2012-2017)
    Figure Genedata AG (Switzerland) Biosimulation Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Genedata AG (Switzerland) Biosimulation Revenue Market Share (%) in Global (2012-2017)
    Figure Global Biosimulation Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
    Figure Global Biosimulation Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Global Biosimulation Price (USD/Unit) Trend Forecast (2017-2022)
    Table Global Biosimulation Sales (K Units) Forecast by Regions (2017-2022)
    Table Global Biosimulation Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global Biosimulation Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global Biosimulation Sales Volume Share Forecast by Regions in 2022
    Table Global Biosimulation Sales (K Units) Forecast by Application (2017-2022)
    Figure Global Biosimulation Sales Volume Market Share Forecast by Application (2017-2022)
    Figure Global Biosimulation Sales Volume Market Share Forecast by Application in 2022
    Table Global Biosimulation Sales (K Units) Forecast by Segmentation (2017-2022)
    Figure Global Biosimulation Sales (K Units) Forecast by Segmentation (2017-2022)
    Figure Global Biosimulation Sales Volume Market Share Forecast by Segmentation in 2022
    Table Global Biosimulation Sales (K Units) Forecast by Phase (2017-2022)
    Figure Global Biosimulation Sales (K Units) Forecast by Phase (2017-2022)
    Figure Global Biosimulation Sales Volume Market Share Forecast by Phase in 2022
    Figure United States Biosimulation Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
    Figure United States Biosimulation Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure United States Biosimulation Price (USD/Unit) Trend Forecast (2017-2022)
    Table United States Biosimulation Sales (K Units) Forecast by Regions (2017-2022)
    Table United States Biosimulation Sales Volume Share Forecast by Regions (2017-2022)
    Figure United States Biosimulation Sales Volume Share Forecast by Regions (2017-2022)
    Figure United States Biosimulation Sales Volume Share Forecast by Regions in 2022
    Table United States Biosimulation Sales (K Units) Forecast by Application (2017-2022)
    Figure United States Biosimulation Sales Volume Market Share Forecast by Application (2017-2022)
    Figure United States Biosimulation Sales Volume Market Share Forecast by Application in 2022
    Table United States Biosimulation Sales (K Units) Forecast by Segmentation (2017-2022)
    Figure United States Biosimulation Sales (K Units) Forecast by Segmentation (2017-2022)
    Figure United States Biosimulation Sales Volume Market Share Forecast by Segmentation in 2022
    Table United States Biosimulation Sales (K Units) Forecast by Phase (2017-2022)
    Figure United States Biosimulation Sales (K Units) Forecast by Phase (2017-2022)
    Figure United States Biosimulation Sales Volume Market Share Forecast by Phase in 2022